OMRON (6645) Q4 2025 earnings summary

Executive summary

• FY2024 net sales decreased 2.1% year-over-year to ¥801.8bn, mainly due to weak demand in Industrial Automation and Devices & Module Solutions, and lower demand in China for Healthcare.

• Operating income rose 57.4% year-over-year to ¥54.0bn, driven by improved margins and cost reductions from structural reforms.

• Net income attributable to shareholders doubled to ¥16.3bn, despite one-time restructuring costs.

• Structural reform expenses totaled ¥27.8bn, including ¥22.0bn for headcount and capacity optimization.

• IAB and SSB segments achieved profit growth, while HCB and DMB faced declines from weak demand and competition.

Financial highlights

• Gross profit margin improved by 2.2 percentage points to 44.5%; operating income margin increased to 6.7% from 4.2%.

• Free cash flow turned positive at ¥7.9bn, up ¥70.1bn year-over-year; cash and equivalents rose to ¥149.0bn.

• Net income per share increased to ¥82.63.

• Dividend payout ratio reached 253.3%.

• ROE improved to 2.1% from 1.1%; ROIC rose to 1.8% from 1.0%.

Outlook and guidance

• FY2025/FY2026 forecasts presented as a range due to U.S. tariff policy uncertainty; net sales expected between ¥820.0bn and ¥835.0bn, operating income between ¥56.0bn and ¥65.0bn.

• Net income forecasted at ¥29.0bn–¥35.5bn; ROE and ROIC expected to rise to approximately 3–4%.

• Full-year dividend guidance maintained at ¥104 per share.

• Guidance reflects up to ¥16bn profit and ¥15bn sales risk from U.S. tariffs.

• Increased R&D investment in IAB by ¥5bn year-over-year to strengthen competitiveness.